7Baggers
 will tempest therapeutics inc. stock reach all time highs in 2025  newser.com Sun, 09 Nov 2025 18:27:41 GMT
 Tempest Therapeutics Shrinks Losses And Slashes R&D Costs  Finimize Thu, 06 Nov 2025 19:19:55 GMT
 tempest therapeutics reports q3 2025 financial results  TipRanks Thu, 06 Nov 2025 05:38:19 GMT
 tempest therapeutics shrinks losses and slashes r&d costs  Finimize Wed, 05 Nov 2025 18:17:39 GMT
 Tempest Therapeutics reports Q3 EPS (79c) vs ($5.32) last year  TipRanks Wed, 05 Nov 2025 08:00:00 GMT
 Tempest Therapeutics Q3 EPS USD -0.79  MarketScreener Wed, 05 Nov 2025 08:00:00 GMT

Tempest Therapeutics Inc
(NASDAQ:TPST) 


Tempest Therapeutics Inc., a clinical-stage oncology company, is dedicated to the development of small molecules that combine targeted and immune-mediated mechanisms with the potential to treat various tumors. The company is headquartered in South San Francisco, California.

Founded: 2011
Sector: LIFE SCIENCES
Industry: PHARMACEUTICAL PREPARATIONS

Share this website to your friends